Regulator flags concerns on Australian Clinical's buyout offer for Healius

Healius

20/07/2023 24:41

July 20 (Reuters) - Australia's competition watchdog on
Thursday raised concerns over Australian Clinical Labs'  ACL.AX 
A$1.52 billion ($1.03 billion) buyout offer for medical centre
operator Healius  HLS.AX , who had rejected the proposal in May.
    The Australian Competition and Consumer Commission said the
acquisition would lessen competition in the Australian pathology
services markets. 
    
    ($1 = 1.4775 Australian dollars)
    
    

 (Reporting by Navya Mittal in Bengaluru; Editing by Sherry
Jacob-Phillips)
 ((Navya.Mittal@thomsonreuters.com;))